0 results found with selected filters. Please refine the filters. Redirecting to initial search..
How to display a graph
Please select the measurements of same unit in the left filter pane to view the graph.
downloaded on: 2025/11/14 00:08:02
| Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Value |
Units |
SEM |
SD |
Method |
Method Site |
Method Duration |
Post Insult Time Value |
Record ID |
Study ID |
| LEW.1F |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56.0 days-234.0 days |
11 |
17.0 |
d |
0.9 |
3.0 |
in vivo visual assessment |
|
1.296E7 |
|
70133 |
1282 |
| LEW.1F |
subjects with ankylosis to total subjects with arthritis ratio |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56.0 days-234.0 days |
11 |
0.0 |
% |
|
|
in vivo visual assessment |
tail |
1.296E7 |
|
70135 |
1282 |
| LEW.1F |
percentage of study population developing experimental arthritis during a period of time |
pristane (150 ul) |
Lu S, et al., Eur J Hum Genet 2002 Aug;10(8):475-83. |
joint integrity trait |
female |
56.0 days-84.0 days |
8 |
100.0 |
% |
|
|
in vivo visual assessment |
|
0.0 |
|
69814 |
1163 |
| LEW.1F |
percentage of study population developing experimental arthritis during a period of time |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56.0 days-234.0 days |
11 |
100.0 |
% |
|
|
in vivo visual assessment |
|
1.296E7 |
|
70129 |
1282 |
| LEW.1F |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Lu S, et al., Eur J Hum Genet 2002 Aug;10(8):475-83. |
joint integrity trait |
male |
56.0 days-84.0 days |
14 |
31.0 |
d |
7.0 |
26.19 |
in vivo visual assessment |
|
0.0 |
|
69817 |
1163 |
| LEW.1F |
arthritic paw count |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56.0 days-234.0 days |
11 |
3.4 |
null |
0.21 |
0.7 |
in vivo visual assessment |
tail |
1.296E7 |
|
70138 |
1282 |
| LEW.1F |
percentage of study population developing experimental arthritis during a period of time |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56.0 days-98.0 days |
10 |
100.0 |
% |
|
|
in vivo visual assessment |
|
0.0 |
|
69661 |
1159 |
| LEW.1F |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56.0 days-98.0 days |
10 |
17.0 |
d |
1.26 |
4.0 |
in vivo visual assessment |
|
0.0 |
|
69669 |
1159 |
| LEW.1F |
percentage of study population developing chronic experimental arthritis during a period of time |
pristane (150 ul) |
Vingsbo C, et al., Am J Pathol 1996 Nov;149(5):1675-83 |
joint integrity trait |
both |
56.0 days-98.0 days |
10 |
100.0 |
% |
|
|
in vivo visual assessment |
|
0.0 |
|
69677 |
1159 |
| LEW.1F |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Lu S, et al., Eur J Hum Genet 2002 Aug;10(8):475-83. |
joint integrity trait |
female |
56.0 days-84.0 days |
8 |
18.0 |
d |
1.0 |
2.83 |
in vivo visual assessment |
|
0.0 |
|
69818 |
1163 |
| LEW.1F |
percentage of study population developing experimental arthritis during a period of time |
pristane (150 ul) |
Lu S, et al., Eur J Hum Genet 2002 Aug;10(8):475-83. |
joint integrity trait |
male |
56.0 days-84.0 days |
14 |
86.0 |
% |
|
|
in vivo visual assessment |
|
0.0 |
|
69813 |
1163 |
|